ArticleDiabetes, obesity & metabolism2019

Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized

Desiree Abdurrachim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.